← FDA Drug Approvals (Drugs@FDA)

CISATRACURIUM BESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2018-03-30

Drug application

FDA Application #

ANDA203236

Application type

Abbreviated New Drug Application (Generic)

Brand name

CISATRACURIUM BESYLATE

Generic name

CISATRACURIUM BESYLATE

Active ingredients

CISATRACURIUM BESYLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

2018-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown